US "cyberchondriacs" do not check on-line sources

6 November 2006

Three quarters of US adults who regularly search for health care information on-line (sometimes known as "cyberchondriacs;" Marketletter August 7) do not check the source and date to verify the data's quality, according to a survey conducted by the Pew Internet & American Life Project.

The research also found that 10 million US residents, or 7% of the country's Internet users, perform on-line searches for information about diseases, treatments, prescription drugs and other health-related issues.

Most respondents were said by Pew to be using general search engines such as Google and Yahoo, and the survey's author, Susannah Fox, claimed that the failure of people to examine sources and dates of data was because "web sites aren't listing it." Adriana Cronin-Lukas, a social media expert who advises firms about on-line communication, said the problem was probably a lack of sophistication among early Internet users. She said: "by using Google and Yahoo's advanced search options, limiting the responses to, say, three months is easy. Some search engines list results by date or importance. Bloggers and the better media outlets link directly to their sources and have time stamps."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight